Core Insights - Bayer has officially launched its first innovation center in China, the Bayer Yizhuang Open Innovation Center, marking a strategic shift in the perception of China from a large market to an innovation hub [1][3] - The center aims to integrate local innovation resources and accelerate the deep integration of industry, academia, and research, focusing on innovative drugs in areas such as cardiovascular diseases and oncology [1][3] Group 1 - The Bayer Yizhuang Open Innovation Center is a significant strategic milestone for Bayer in China, serving as a core hub for collaboration with local innovation forces [3] - The center is expected to foster a series of collaborative outcomes and support Chinese companies in expanding internationally [3] - The launch coincided with a themed event that gathered top scientists, scholars, and business leaders from China and Europe to discuss topics such as digital healthcare and the clinical translation of research results [3]